Register entry
- Registered sites
- 1
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Finished drug manufacture1transfill1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| RTA Pediatric Care Inc. | 106 W Landis Ave, Vineland, New Jersey (NJ) 08360, United States (USA) | Finished drug manufacture, transfill | 3008835929827906103 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| OXYGEN | OXYGEN | gas, respiratory (inhalation) | 69241-001NDA |
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is RTA Pediatric Care Inc. FDA approved?
- RTA Pediatric Care Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are RTA Pediatric Care Inc.'s drugs manufactured?
- The FDA register lists Vineland, NJ. Registered operations: finished drug manufacture, transfill.
- What drugs does RTA Pediatric Care Inc. make?
- 1 product is listed under RTA Pediatric Care Inc. in the openFDA NDC Directory, most often as gas. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.